Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Camson Bio Technologies Ltd (538858)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538858 NSE: Agriculture | Small Cap | Camson Bio Share Price
₹3.31 0.00 (0.00%)
As on 11-May'20 18:01
Camson Bio Technologies Ltd (538858)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538858 NSE: Agriculture | Small Cap | Camson Bio Share Price
₹3.31 0.00 (0.00%)
As on 11-May'20 18:01
Key Metrics
Valuation Multiples
Market Cap
₹10 Cr.
Current Price
₹3.3
52-Week Low / High
₹3 / 3
TTM EPS
₹-3.7
TTM Sales
₹19.3 Cr.
Book Value per Share
₹22.2
P/E Ratio
0.00
Industry PE
15.5
Price to Book (P/B)
0.15
Price to Sales (P/S)
0.51
EV/EBITDA
43.86
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-15.83%
Return on Capital Employed (ROCE)
-4.96%
Return on Assets (ROA)
-7.89%
Operating Profit Margin
0.2%
Net Profit Margin
-58.09%
Gross Profit Margin
-20.9%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-74.21%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
24.46%
Pledged shares (%) of Promoter's holding (%)
26.49%
Reserves
₹37 Cr.
Equity
₹30 Cr.
Face Value
₹10
All Time Low / High
₹3.31 / 252.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 25.4% | 24.4% | 16.9% | 14.8% | 7.1% | 4.1% | -15.5% | -12.2% | -4.9% | -19.2% | - |
| Value Creation Index ⓘ | 0.8 | 0.7 | 0.2 | 0.1 | -0.5 | -0.7 | -2.1 | -1.9 | -1.4 | -2.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 80 | 98.7 | 112 | 120 | 146 | 169 | 25.4 | 10.4 | 19.3 | 5 | 5 |
| Sales YoY Gr. | - | 23.5% | 13.7% | 6.6% | 21.8% | 16.3% | -85% | -59.3% | 86.6% | -74.2% | - |
| Adj EPS ⓘ | 8.5 | 12.1 | 11.4 | 12.7 | 6.3 | 1 | -12.6 | -7.7 | -3.7 | -7.3 | -8.4 |
| YoY Gr. | - | 42.7% | -5.9% | 11% | -50.8% | -83.7% | -1336.3% | NA | NA | NA | - |
| BVPS (₹) ⓘ | 43.2 | 57.9 | 69.3 | 80.8 | 80.8 | 88 | 34.8 | 25.7 | 22.2 | 14.9 | 12.4 |
| Adj Net Profit ⓘ | 13.7 | 22 | 20.7 | 23 | 15.8 | 3.1 | -37.8 | -23.2 | -11.2 | -21.9 | -25 |
| Cash Flow from Ops. ⓘ | 10.5 | -1.9 | 10.2 | -13.5 | -14.7 | 14.1 | -10 | 4.6 | 1.8 | 0 | - |
| Debt/CF from Ops. ⓘ | 0.1 | -0.6 | 1.2 | -3 | -2.7 | 2.6 | -4.7 | 10.1 | 26.7 | 554260.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -26.5% | -49.1% | -41.9% | -74.2% | ||||
| Adj EPS ⓘ | -198.3% | -203.2% | NA | NA | ||||
| BVPSⓘ | -11.2% | -28.7% | -24.6% | -32.9% | ||||
| Share Price | -19.9% | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 23.7 | 24.1 | 17.8 | 16 | 8.1 | 1.3 | -20.5 | -25.6 | -15.6 | -39.3 | -61.4 |
| Op. Profit Mgn % ⓘ | 20.3 | 22.8 | 19.6 | 23.6 | 17 | 10.9 | -56.6 | -127.7 | 0.2 | -329.4 | -439.3 |
| Net Profit Mgn % ⓘ | 17.1 | 22.3 | 18.5 | 19.2 | 10.8 | 1.8 | -148.9 | -224.1 | -58.2 | -440 | -516.8 |
| Debt to Equity ⓘ | 0 | 0 | 0.1 | 0.3 | 0.2 | 0.1 | 0.5 | 0.6 | 0.7 | 1.1 | - |
| Working Cap Days ⓘ | 142 | 226 | 297 | 354 | 385 | 382 | 1,745 | 1,871 | 899 | 3,057 | 1,678 |
| Cash Conv. Cycle ⓘ | 125 | 188 | 237 | 270 | 275 | 299 | 1,356 | 606 | 483 | 2,737 | -1,110 |
Valuation of Camson Bio - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 | 26.49 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 |
|---|---|---|---|---|---|---|---|
| Sales | 112.24 | 136.04 | 190.89 | 203.02 | 62.12 | 15.39 | 19.31 |
| Operating Expenses ⓘ + | 90.29 | 106.64 | 166.18 | 185.91 | 76.98 | 29.83 | 19.28 |
| Operating Profit ⓘ | 21.95 | 29.40 | 24.71 | 17.11 | -14.87 | -14.43 | 0.03 |
| Operating Profit Margin (%) | 19.6% | 21.6% | 12.9% | 8.4% | -23.9% | -93.8% | 0.2% |
| Other Income ⓘ + | 0.49 | 0.30 | 0.53 | 6.42 | 1.23 | 3.94 | 1.30 |
| Interest ⓘ | 0.36 | 2.01 | 3.88 | 5.09 | 6.65 | 6.78 | 5.36 |
| Depreciation ⓘ | 1.64 | 3.35 | 5.11 | 14 | 23.22 | 7.69 | 7.19 |
| Profit Before Tax ⓘ | 20.45 | 24.34 | 12.69 | 4.44 | -43.51 | -24.97 | -11.22 |
| Tax ⓘ | -0.28 | 0.56 | -0.48 | 4.33 | -2.09 | -0.17 | 0 |
| Profit After Tax | 20.72 | 23.78 | 13.17 | 0.11 | -41.42 | -24.80 | -11.22 |
| PAT Margin (%) | 18.5% | 17.5% | 6.9% | 0.1% | -66.7% | -161.0% | -58.1% |
| Adjusted EPS (₹) | 11.4 | 13.0 | 5.2 | 0.7 | -13.2 | -9.9 | -3.7 |
| Dividend Payout Ratio (%) | 8.80% | 7.70% | 19.10% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 125.59 | 147 | 204.27 | 263.25 | 101.63 | 75.10 | 66.66 | ||||
| Debt + | 12.39 | 38.42 | 37.07 | 45.66 | 59.80 | 45.87 | 48.70 | ||||
| Minority Interest | 0 | 0.27 | 0.26 | 2.93 | 2.26 | 0 | 0 | ||||
| Trade Payables | 7.50 | 17.93 | 11.02 | 20.56 | 15.08 | 7.51 | 8.28 | ||||
| Others Liabilities ⓘ | 7.68 | 29.35 | 38.55 | 15.33 | 15.30 | 15.51 | 16.72 | ||||
| Total Liabilities ⓘ | 153.17 | 232.99 | 291.18 | 347.73 | 194.07 | 143.99 | 140.36 | ||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 34.63 | 78.42 | 109.62 | 153.37 | 130.44 | 106.29 | 100.19 | ||||
| CWIP ⓘ | 22.12 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | ||||
| Investments ⓘ | 0.01 | 0 | 0 | 0 | 0 | 1.47 | 3.40 | ||||
| Inventories | 40.01 | 39.59 | 40.41 | 27.97 | 10.89 | 11.92 | 40.35 | ||||
| Trade Receivables | 46.93 | 80.58 | 93.55 | 157.75 | 28.62 | 3.72 | 5.11 | ||||
| Cash Equivalents | 0.86 | 1.69 | 1.96 | 1.46 | 0.59 | 0.21 | 0.26 | ||||
| Others Assets ⓘ | 8.61 | 32.71 | 45.63 | 7.17 | 23.52 | 20.39 | -8.96 | ||||
| Total Assets ⓘ | 153.17 | 232.99 | 291.18 | 347.73 | 194.07 | 143.99 | 140.36 | ||||
| PARTICULARS | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 |
|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 10.15 | -13.47 | -16.37 | 18.97 | -18.89 | 4.56 | 5.49 |
| Cash Flow From Investing Activity ⓘ + | -20.18 | -25.02 | -34.59 | -54.20 | 11.88 | 2.72 | -3.41 |
| Cash Flow From Financing Activity ⓘ + | 8.95 | 39.32 | 51.23 | 34.73 | 6.66 | -7.33 | -2.05 |
| Net Cash Flow ⓘ | -1.08 | 0.83 | 0.27 | -0.50 | -0.35 | -0.04 | 0.03 |
| PARTICULARS | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 16.5 | 17.45 | 7.5 | 0.05 | -22.71 | -28.06 | -15.83 | |||
| ROCE (%) | 15.07 | 15.47 | 7.05 | 3.3 | -15.58 | -12.81 | -4.96 | |||
| Asset Turnover Ratio | 0.73 | 0.7 | 0.73 | 0.64 | 0.23 | 0.09 | 0.14 | |||
| PAT to CFO Conversion(x) | 0.49 | -0.57 | -1.24 | 172.45 | N/A | N/A | N/A | |||
| Working Capital Days | ||||||||||
| Receivable Days | 152.60 | 171.10 | 166.50 | 225.90 | 547.60 | 383.40 | 83.40 | |||
| Inventory Days | 130.10 | 106.80 | 76.50 | 61.50 | 114.20 | 270.40 | 494 | |||
| Payable Days | 646.40 | 168.30 | 57.10 | 72.90 | 184.50 | 540.80 | 374.30 | |||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Camson Bio Technologies Ltd FAQs
The current trading price of Camson Bio on 11-May-2020 18:01 is ₹3.31.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-May-2020 the market cap of Camson Bio stood at ₹9.93 Cr
The latest P/E ratio of Camson Bio as of 10-May-2020 is 0.00.
The latest P/B ratio of Camson Bio as of 10-May-2020 is 0.27.
The 52-week high of Camson Bio is ₹3.31 and the 52-week low is ₹3.31.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Camson Bio is ₹4.87 ( Cr.) .
Data is not available for this company.
The key valuation ratios of Camson Bio Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Camson Bio Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Camson Bio Technologies Ltd
Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology products
The Company has a strong presence in the Indian market and has unique research and intellectual proprietary which gives the Company an edge over others. Its proprietary technology platform consists of microorganism database, superior proprietary seeds germplasm, screening technology, biocides, biofertilisers and hybrid seeds.
Camson has developed many unique biocides for plant protection and hybrid seeds for improved productivity. Their superior technology in crop transformation and functional genomics has helped in developing new products which are first of its kind in the country.
The infrastructure set up of the Company is at Bangalore North. The set up provides for a total composite production. It is State-of-the-art and spread over 20 acres of land. This affords a high level of space for multi-product production, simultaneously. The Company constantly upgrades its production facilities to keep pace with the increased demand for its products as also for producing a wider range of products pursuant to the success achieved on its research front.
Product range of the company includes:
- Bio Fungicides
- Bio Insecticides
- Bio Stimulants
- Bio Fertilisers
- Hybrid Seeds
Achievements/ recognition:
- Camson Bio Technologies has been recognized, for the second year in succession, as one of the fastest growing technology companies and placed at 17th position, in the Technology 50 India 2008 programme conducted by Deloitte Touche Tohmatsu, Asia Pacific.
- Camson was declared a Stellar performer for the second year in a row under Technology Fast 500 Asia Pacific Ranking and CEO Survey 2008, obtaining 131st rank out of 500 companies identified by Deloitte.
You have 33 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
